Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-γ secretion pathway

Journal of Autoimmunity

Volumn 13, Issue 4, 1999, Pages 383-392

  Ablamunits, Vitaly ^a   Quintana, Francisco ^a   Reshef, Tamara ^a   Elias, Dana ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Autoimmune diabetes; Cyclophosphamide; Interferon gamma

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE;

ALLOGRAFT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CYTOKINE RELEASE; CYTOSTASIS; DIABETES MELLITUS; DRUG EFFECT; GRAFT REJECTION; HYPERGLYCEMIA; IMMUNE RESPONSE; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033376438     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0331     Document Type: Article

References (48)

1. Reinolds J.E.F. Antineoplastic agents and immunosuppressants. Martindale. The Extra Pharmacopoeia. 1993;The Pharmaceutical Press, London.
2. Mayumi H., Good R.A. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barrier by a tolerance- inducing method using cyclophosphamide. J. Exp. Med. 169:1989;213-238.
3. Rosenberg S.A., Spiess P., Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science. 233:1986;1318-1321.
4. Mowat A.M., Strobel S., Drummond H.E., Ferguson A. Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumine by cyclophosphamide. Immunology. 45:1982;105-113.
5. Nakajima H., Hiyama Y., Takamori H., Tsukada W. Cell-mediated transfer of collagen-induced arthritis in mice and its application to the analysis of the inhibitory effects of interferon-gamma and cyclophosphamide. Clin. Exp. Immunol. 92:1993;328-335.
6. Lando Z., Teitelbaum D., Arnon R. Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE. J. Immunol. 123:1979;2156-2160.
7. Harada M., Makino S. Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia. 27:1984;604-606.
8. Yasunami R., Bach J.-F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18:1988;481-484.
9. +T-lymphocytes. Diabetes. 37:1988;1108-1112.
10. Rabinovitch R. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes. 43:1994;613-621.
11. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune disregulation gets the NOD. Immunity. 7:1997;727-738.
12. Campbell I.L., Kay T.W.H., Oxbrow L., Harrison L. Essential role of interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:1991;739-742.
13. Ablamunits V., Elias D., Reshef T., Cohen I.R. Islet T cells secreting IFN-γ in NOD mouse diabetes: arrest by p277 peptide treatment. J. Autoimmun. 11:1998;73-81.
14. Ablamunits V., Elias D., Cohen I.R. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Clin. Exp. Immunol. 115:1999;260-267.
15. Like A.A., Rossini A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science. 193:1976;415-417.
16. Elias D., Prigozhin H., Polak N., Rapaport M., Lohze A.W., Cohen I.R. Autoimmune diabetes induced by the β-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes. 43:1994;992-998.
17. Elias D., Reshef T., Birk O.S., van der Zee R., Walker M.D., Cohen I.R. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65 kDa heat shock protein. Proc. Natl. Acad. Sci. U S A. 88:1991;3088-3091.
18. Yang X., Hayglass K. A simple, sensitive, dual mAb based ELISA for murine gamma interferon determination: comparison with common bioassays. J. Immunoassays. 14:1993;129-148.
19. Sedgwick J.D., Holt P.G. The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. J. Immunol. Meth. 87:1986;37-44.
20. Gerling I.C., Friedman H., Greiner D.L., Shultz L.D., Leiter E.H. Multiple low-dose streptozotocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes. 43:1994;433-440.
21. Charlton B., Bacekj A., Slattery R.M., Mandel T. Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes. 38:1989;441-447.
22. Boitard C., Yasunami R., Dardenne M., Bach J.-F. T cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1989;1669-1680.
23. Hutchins P.R., Cooke A. The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmun. 3:1990;175-185.
24. Peterson J.D., Haskins K. Transfer of diabetes in the NOD- scid mouse by CD4 T-cell clones. Diabetes. 45:1996;328-336.
25. Serreze D.V., Chapman H.D., Varnum D.S., Gerling I., Leiter E.H., Shiltz L.D. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 158:1997;3978-3986.
26. Christianson S.W., Shulz L.D., Leiter E.H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+and CD8+T-cells from diabetic versus pre-diabetic NOD.NON-Thy-1a donors. Diabetes. 42:1993;44-55.
27. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
28. Haskins K., Wegmann D. Diabetogenic T-cell clones. Diabetes. 45:1996;1299-1305.
29. Shehadeh N.N., LaRosa F., Lafferty K.J. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:1993;291-300.
30. Debray-Sachs M., Carnaud C., Boitard C., Cohen H., Gresser I., Bedossa P., Bach J.-F. Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ J. Autoimmun. 4:1991;237-248.
31. Hancock W.W., Polanski M., Zhang J., Blogg N., Weiner H.L. Suppression of insulitis in NOD mice by oral insulin administration ia associated with selective expression of IL-4, IL-10, TGF-β and prostaglandin-E. Am. J. Pathol. 147:1995;1193-1199.
32. Rapoport M.J., Jaramillo A., Zipris D., Lazarus A.H., Serreze D.V., Leiter E.H., Cyopick P., Danska J.S., Delovitch T.L. IL-4 reverses T-cell prolipherative unresponsiveness and prevents the onset of diabetes in NOD mice. J. Exp. Med. 178:1993;87-99.
33. Mueller R., Krahl T., Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 186:1996;1093-1099.
34. Moritani M., Yoshimoto K., Ii S., Kondo M., Iwahana H., Yamaoka T., Sano T., Nakano N., Kikutani H., Itakura M. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. J. Clin. Invest. 98:1996;1851-1859.
35. Elias D., Meilin A., Ablamunits V., Birk O.S., Carmi P., Könen-Waisman S., Cohen I.R. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes. 46:1997;758-764.
36. Leiter E.H. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: Influence of inbred background, sex, and thymus. Proc. Natl. Acad. Sci. U S A. 79:1982;630-634.
37. Rossini A.A., Like A.A., Chick W.L., Appel M.C., Cahill G.F.J. Studies of streptozotocin-induced insulitis and diabetes. Proc. Natl. Acad. Sci. U S A. 74:1977;2485-2489.
38. Hendrickson E., Quin X.-Q., Bump E., Schatz D., Oettinger M., Weaver D. A link between double strand break repair and V(D)J recombination: the scid mutation. Proc. Nat. Acad. Sci. U S A. 88:1991;4061-4065.
39. Rossini A.A., Williams R.M., Appel M.C., Like A.A. Sex differences in the multiple-dose streptozo- tocin model of diabetes. Endocrinology. 108:1978;1518-1520.
40. Cella M., Salusto F., Lanzavecchia A. Origin, maturation and antigen-presenting function of dendritic cells. Curr. Opin. Immunol. 9:1997;10-16.
41. de StGroth B.F. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today. 19:1998;448-454.
42. Constant S.L., Bottomly K. Induction of Th1 and Th2 CD4+T cell responses: The alternative approaches. Annu. Rev. Immunol. 15:1997;297-322.
43. Rothe H., Burkart V., Faust A., Kolb H. Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia. 39:1996;119-122.
44. Leiter E.H., Gerling I.C., Flynn J.C. Spontaneous insulin-dependent diabetes mellitus (IDDM) in nonobese diabetic (NOD) mice: Comparisons with experimentally induced IDDM. McNeil J.H. Experimental models of diabetes. 1999;CRC Press LLC, Boca Raton.
45. Kim Y.T., Steinberg C. Immunologic studies on the induction of diabetes in experimental animals. Cellular basis for the induction of diabetes by streptozotocin. Diabetes. 33:1984;771-777.
46. Lampeter E.F., Homberg M., Quabeck K., Schaefer U.W., Wernet P., Bertrams J., Grosse-Wilde H., Gries F.A., Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet. 341:1993;1243-1244.
47. Sibley R.K., Sutherland D.E., Goets F., Michael A.F. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab. Invest. 53:1985;132-144.
48. Atlan-Gepner C., Bouabdallah R., Valero R., Coso D., Vialettes B. A cyclophosphamide-induced autoimmune diabetes. Lancet. 352:1998;373-374.